section name header

Evidence summaries

First and Second Trimester Serum Tests with and Without First Trimester Ultrasound Tests for Down's Syndrome Screening

Combination of first trimester nuchal translucency and first trimester PAPP-A with one or two other serum tests in first or seconf trimester, and maternal age detects 85-90% of Down´s syndrome at false positive rate of 5%. Level of evidence: "A"

Summary

A Cochrane review [Abstract] 1 included 22 studies with a total of 228 615 pregnancies (including 1067 with Down's syndrome). 32 different test combinations were evaluated formed from combinations of 8 different tests and maternal age; first trimester nuchal translucency (NT) and the serum markers AFP, uE3, total hCG, free betahCG (BhCG), Inhibin A, PAPP-A and ADAM 12.

First trimester NT, first trimester PAPP-A, second trimester BhCG, second trimester uE3, second trimester AFP, second trimester Inhibin A, and maternal age(4 studies, 40 348 women with 266 Down's syndrome) yielded sensitivity of 92% (95% CI 88 to 95) at a 5% false positive rate (FPR).

First trimester PAPP-A, second trimester total hCG, uE3, AFP and maternal age (4 studies, 2 474 women with 236 Down's syndrome) with 1:250 risk and at a fixed cut-point of 5% FPR sensitivity of 85% (95% CI 78 to 89).

First trimester nuchal translucency, second trimester total hCG, uE3, AFP and maternal age (4 studies, 13 708 women with 136 Down's syndrome) yielded at a fixed cut-point of 5% FPR sensitivity of 86% (95% CI 78 to 92).

First trimester nuchal translucency, second trimester total hCG, AFP and maternal age (4 studies, 22 793 women with 135 Down's syndrome) yielded with 1:250 risk at a fixed cut-point of 5% FPR sensitivity of 85% (CI 77 to 91).

First trimester NT and PAPP-A, and second trimester total hCG, uE3, AFP and Inhibin A, and maternal age evaluated (3 studies) estimated a sensitivity of 95% (CI 90 to 97) at a cut-point of 5% FPR.

Meta-analysis of the 6 most frequently evaluated test combinations showed that a test strategy involving maternal age and a combination of first trimester NT and PAPP-A, and second trimester total hCG, uE3, AFP and Inhibin A significantly outperformed other test combinations that involved only one serum marker or NT in the first trimester, detecting about nine out of every 10 Down's syndrome pregnancies at a 5% false positive rate.

Clinical comments

Note

Date of latest search: 12 January 2018

    References

    • Alldred SK, Takwoingi Y, Guo B et al. First and second trimester serum tests with and without first trimester ultrasound tests for Down's syndrome screening. Cochrane Database Syst Rev 2017;(3):CD012599. [PubMed]

Primary/Secondary Keywords